Search

Author/Creator Janes, Jonathan M

1. 199 Baricitinib in patients with systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study. (April 2019)

Authors:
Silk, Maria E; Wallace, Daniel J; Furie, Richard A; Tanaka, Yoshiya; Kalunian, Kenneth C; Mosca, Marta; Petri, Michelle; Dörner, Thomas; Cardiel, Mario H; Bruce, Ian N; Gomez, Elisa; DeLozier, Amy M; Janes, Jonathan M; Linnik, Matthew D; Bono, Stephanie de; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 6(2019)supplement 1
Page Start:
A149
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Issue 10143 (21st July 2018)

Authors:
Wallace, Daniel J; Furie, Richard A; Tanaka, Yoshiya; Kalunian, Kenneth C; Mosca, Marta; Petri, Michelle A; Dörner, Thomas; Cardiel, Mario H; Bruce, Ian N; Gomez, Elisa; Carmack, Tara; DeLozier, Amy M; Janes, Jonathan M; Linnik, Matthew D; de Bono, Stephanie; Silk, Maria E; Hoffman, Robert W
Journal:
Lancet
Issue:
Volume 392:Issue 10143(2018)
Page Start:
222
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial. Issue 11 (22nd February 2018)

Authors:
Tuttle, Katherine R; Brosius, Frank C; Adler, Sharon G; Kretzler, Matthias; Mehta, Ravindra L; Tumlin, James A; Tanaka, Yoshiya; Haneda, Masakazu; Liu, Jiajun; Silk, Maria E; Cardillo, Tracy E; Duffin, Kevin L; Haas, Joseph V; Macias, William L; Nunes, Fabio P; Janes, Jonathan M
Journal:
Nephrology dialysis transplantation
Issue:
Volume 33:Issue 11(2018)
Page Start:
1950
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗